TABLE 3.
Quantitative data synthesis for the association of comorbidities and hospitalisation of COVID‐19
| Comorbidity | Number of studies | Total cases | OR | CI | p value a | I 2 (%) | Tau2 |
|---|---|---|---|---|---|---|---|
| Asthma | 21 | 350,437 | 1.22 | 1.02–1.45 | 0.03 | 92.5% | 0.11 |
| Chronic obstructive pulmonary disease | 24 | 361,466 | 3.68 | 2.97–4.55 | <0.001 | 94.8% | 0.17 |
| Congestive heart failure | 17 | 161,879 | 6.80 | 4.97–9.31 | <0.001 | 95.9% | 0.35 |
| Coronary heart disease | 15 | 135,539 | 4.40 | 3.15–6.16 | <0.001 | 96.8% | 0.36 |
| Diabetes | 34 | 786,373 | 3.90 | 3.29–4.63 | <0.001 | 98.3% | 0.21 |
| Hypertension | 31 | 768,334 | 3.89 | 3.34–4.54 | <0.001 | 98.0% | 0.15 |
| Obesity | 26 | 372,468 | 1.98 | 1.59–2.46 | <0.001 | 99.0% | 0.27 |
| Renal disease | 27 | 391,522 | 5.84 | 4.51–7.56 | <0.001 | 97.4% | 0.35 |
Abbreviations: CI, confidence interval; OR, odds ratio.
a
p < 0.05.